We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. As of December 31, 2025, we operated, directly or indirectly through hospital and health system joint ventures, 418 imaging centers located in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas and New York.
$55.53
+$0.22 (+0.40%)
Price from 5 days ago
Operating margin is thin at 3.04%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 11.5%, still solid. Margins contracted 2.7pp, which offsets some of the top-line progress.
ROIC dropped from 4.11% to 1.67%, capital efficiency is deteriorating. Net debt of $1.12B represents 13.1x FCF, leverage limits flexibility.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$2.14B
▲ +11.5% YoY
Net Income (TTM)
-$14M
▼ -767.8% YoY
Op. Margin
2.90%
▼ -2.7pp YoY
ROIC
1.77%
▼ -2.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$102M
▲ +90.4% YoY
Op. Cash Flow (TTM)
$336M
▲ +28.2% YoY
Net Debt
$1.51B
Cash & Equiv.
$455M
5Y CAGR: +13.7%
5Y CAGR: -9.3%
Continue Research